Population Genetics has developed and patented technologies that can quickly and economically find, characterise and quantify true genetic variants responsible for disease, disease resistance and drug response.

We make these technologies commercially available via service, licensing and partnering models, addressing primarily the agricultural biotechnology, infectious disease and cancer markets.

Our platforms and technologies contribute to a more comprehensive understanding of the role of genetic variation in disease and health by enabling the discovery of actionable genomic information.


Comments are closed.